BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15641142)

  • 1. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.
    Chen YD; Zhou ZG; Wang Z; Gao HK; Yan WW; Wang C; Zhao GP; Peng XH
    World J Gastroenterol; 2005 Jan; 11(4):538-44. PubMed ID: 15641142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of analogs of pituitary adenylate cyclase activating polypeptide on acute pancreatitis in rats].
    Chen YD; Zhou ZG; Yan WW; Wang Z; Gao HK; Zheng XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):64-8. PubMed ID: 15702783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats.
    Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD
    Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
    Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
    Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On PACAP-aggravated experimental acute pancreatitis].
    Chen Y; Zhou Z; Chen Y; Wang Z; Gao H; Zheng X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):964-9. PubMed ID: 15646343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.
    Kirchgessner AL; Liu MT
    Anat Rec; 2001 Jan; 262(1):91-100. PubMed ID: 11146432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase activating polypeptide (PACAP) redistributes the blood within the pancreas of anesthetized rats.
    Carlsson PO; Ostenson CG; Efendic S; Langel U; Jansson L
    Regul Pept; 1996 Jul; 63(2-3):123-8. PubMed ID: 8837220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP-(1-38) as neurotransmitter in pig pancreas: receptor activation revealed by the antagonist PACAP-(6-38).
    Tornøe K; Hannibal J; Fahrenkrug J; Holst JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G436-46. PubMed ID: 9277423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat.
    Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ
    Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACAP modulation of the colon-inferior mesenteric ganglion reflex in the guinea pig.
    Ermilov LG; Schmalz PF; Miller SM; Szurszewski JH
    J Physiol; 2004 Oct; 560(Pt 1):231-47. PubMed ID: 15284351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors.
    Yamada H; Watanabe M; Yada T
    Regul Pept; 2004 Dec; 123(1-3):147-53. PubMed ID: 15518905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PAC(1) receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo.
    Lamouche S; Yamaguchi N
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R510-8. PubMed ID: 11208582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.